Veradermics (MANE) Current Assets (2024 - 2026)

Veradermics (MANE) posted Current Assets of $397.1 million for Q1 2026, up 160.38% on a QoQ basis from $152.5 million in Q4 2025.

Veradermics (MANE) Current Assets (2024 - 2026) Analysis & Trends

Veradermics' Current Assets history runs 3 years deep, the most recent figure standing at $397.1 million for Q1 2026.

  • Quarterly Current Assets changed N/A year-over-year to $397.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $397.1 million (changed N/A YoY) and the FY2025 annual result came in at $152.5 million, up 174.59% from the prior year.
  • Current Assets was $397.1 million for Q1 2026 at Veradermics, up from $152.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $397.1 million in Q1 2026 and bottomed at $55.5 million in Q4 2024.
  • A 3-year average of $201.7 million and a median of $152.5 million in 2025 frame the typical range for Current Assets.
  • Peak annual rise in Current Assets reached 174.59% in 2025, while the deepest fall reached 174.59% in 2025.
  • Veradermics' Current Assets stood at $55.5 million in 2024, then surged by 174.59% to $152.5 million in 2025, then surged by 160.38% to $397.1 million in 2026.
  • Business Quant data shows MANE's Current Assets at $397.1 million in Q1 2026, $152.5 million in Q4 2025, and $55.5 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 289.93 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 73.04 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 6.60 Bn
4 NuCana 279.75 Bn 279.75 Bn - 35.73 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 11.73 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 18.21 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 521.86 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 8.07 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.97 Bn
10 Veradermics 2.63 Bn 2.63 Bn - 397.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 397.07 Mn
Dec 31, 2025 152.49 Mn
Dec 31, 2024 55.54 Mn